COVID Fight: Cipla Wants To Launch Affordable Favipiravir Drug In Indiaby OB Bureau 4 years ago 0 New Delhi: Leading pharmaceutical company Cipla has sought permission to launch Favipiravir, an anti-viral drug, in India to fight against ...
More Researchers Advocate Remdesivir For Treatment Of COVID-19 Patientsby OB Bureau 4 years ago 0 New York: Remdesivir, the anti-viral drug that has shown promise in the fight against COVID-19, has been backed by more ...
3rd Pharma Company Announces Anti-Viral Drug To Treat COVID-19 Patients In Indiaby OB Bureau 5 years ago 0 Another anti-viral drug for the treatment of COVID-19 has been launched, this time by pharma major Cipla. To be sold ...